-
1
-
-
31144459985
-
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
-
DOI 10.1038/nature04296, PII NATURE04296
-
Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, Olson Jr JA, Marks JR, Dressman HK, West M, Nevins JR (2006) Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439: 353-357. (Pubitemid 43128862
-
(2006)
Nature
, vol.439
, Issue.7074
, pp. 353-357
-
-
Bild, A.H.1
Yao, G.2
Chang, J.T.3
Wang, Q.4
Potti, A.5
Chasse, D.6
Joshi, M.-B.7
Harpole, D.8
Lancaster, J.M.9
Berchuck, A.10
Olson Jr., J.A.11
Marks, J.R.12
Dressman, H.K.13
West, M.14
Nevins, J.R.15
-
2
-
-
0031036307
-
Raf-1/bcl-2 phosphorylation: A step from microtubule damage to cell death
-
Blagosklonny MV, Giannakakou P, el-Deiry WS, Kingston DG, Higgs PI, Neckers L, Fojo T (1997) Raf-1/bcl-2 phosphorylation: A step from microtubule damage to cell death. Cancer Res 57: 130-135. (Pubitemid 27020341
-
(1997)
Cancer Research
, vol.57
, Issue.1
, pp. 130-135
-
-
Blagosklonny, M.V.1
Giannakakou, P.2
El-Deiry, W.S.3
Kingston, D.G.I.4
Higgs, P.I.5
Neckers, L.6
Fojo, T.7
-
3
-
-
19744368302
-
Cancer of the ovary
-
Cannistra SA (2004) Cancer of the ovary. N Engl J Med 351: 2519-2529
-
(2004)
N Engl J Med
, vol.351
, pp. 2519-2529
-
-
Cannistra, S.A.1
-
4
-
-
61449106520
-
Survival-related profile, pathways, and transcription factors in ovarian cancer
-
Crijns AP, Fehrmann RS, De Jong S, Gerbens F, Meersma GJ, Klip HG, Hollema H, Hofstra RM, te Meerman GJ, De Vries EG, van Der Zee AG (2009) Survival-related profile, pathways, and transcription factors in ovarian cancer. PLoS Med 6: E24
-
(2009)
PLoS Med
, vol.6
-
-
Crijns, A.P.1
Fehrmann, R.S.2
De Jong, S.3
Gerbens, F.4
Meersma, G.J.5
Klip, H.G.6
Hollema, H.7
Hofstra, R.M.8
Te Meerman, G.J.9
De Vries, E.G.10
Van Der Zee, A.G.11
-
5
-
-
0026648940
-
ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients
-
Dabholkar M, Bostick-Bruton F, Weber C, Bohr VA, Egwuagu C, Reed E (1992) ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients. J Natl Cancer Inst 84: 1512-1517
-
(1992)
J Natl Cancer Inst
, vol.84
, pp. 1512-1517
-
-
Dabholkar, M.1
Bostick-Bruton, F.2
Weber, C.3
Bohr, V.A.4
Egwuagu, C.5
Reed, E.6
-
6
-
-
0035093544
-
Cisplatinum and taxol induce different patterns of p53 phosphorylation
-
Damia G, Filiberti L, Vikhanskaya F, Carrassa L, Taya Y, D'incalci M, Broggini M (2001) Cisplatinum and taxol induce different patterns of p53 phosphorylation. Neoplasia 3: 10-16
-
(2001)
Neoplasia
, vol.3
, pp. 10-16
-
-
Damia, G.1
Filiberti, L.2
Vikhanskaya, F.3
Carrassa, L.4
Taya, Y.5
D'Incalci, M.6
Broggini, M.7
-
7
-
-
82355188205
-
Neurotrophins acting via TRKB receptors activate the JAGGED1-NOTCH2 cell-cell communication pathway to facilitate early ovarian development
-
Dorfman MD, Kerr B, Garcia-Rudaz C, Paredes AH, Dissen GA, Ojeda SR (2011) Neurotrophins acting via TRKB receptors activate the JAGGED1-NOTCH2 cell-cell communication pathway to facilitate early ovarian development. Endocrinology 152: 5005-5016
-
(2011)
Endocrinology
, vol.152
, pp. 5005-5016
-
-
Dorfman, M.D.1
Kerr, B.2
Garcia-Rudaz, C.3
Paredes, A.H.4
Dissen, G.A.5
Ojeda, S.R.6
-
8
-
-
46249088370
-
Lumi: A pipeline for processing Illumina microarray
-
DOI 10.1093/bioinformatics/btn224
-
Du P, Kibbe WA, Lin SM (2008) Lumi: A pipeline for processing Illumina microarray. Bioinformatics 24: 1547-1548. (Pubitemid 351911712
-
(2008)
Bioinformatics
, vol.24
, Issue.13
, pp. 1547-1548
-
-
Du, P.1
Kibbe, W.A.2
Lin, S.M.3
-
9
-
-
0032441150
-
Cluster analysis and display of genome-wide expression patterns
-
DOI 10.1073/pnas.95.25.14863
-
Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868. (Pubitemid 29003722
-
(1998)
Proceedings of the National Academy of Sciences of the United States of America
, vol.95
, Issue.25
, pp. 14863-14868
-
-
Eisen, M.B.1
Spellman, P.T.2
Brown, P.O.3
Botstein, D.4
-
10
-
-
79960304114
-
Trastuzumab and pertuzumab produce changes in morphology and oestrogen receptor signalling in ovarian cancer xenografts revealing new treatment strategies
-
Faratian D, Zweemer AJ, Nagumo Y, Sims AH, Muir M, Dodds M, Mullen P, Um I, Kay C, Hasmann M, Harrison DJ, Langdon SP (2011) Trastuzumab and pertuzumab produce changes in morphology and oestrogen receptor signalling in ovarian cancer xenografts revealing new treatment strategies. Clin Cancer Res 17: 4451-4461
-
(2011)
Clin Cancer Res
, vol.17
, pp. 4451-4461
-
-
Faratian, D.1
Zweemer, A.J.2
Nagumo, Y.3
Sims, A.H.4
Muir, M.5
Dodds, M.6
Mullen, P.7
Um, I.8
Kay, C.9
Hasmann, M.10
Harrison, D.J.11
Langdon, S.P.12
-
11
-
-
0031906084
-
The role of DNA mismatch repair in drug resistance
-
Fink D, Aebi S, Howell SB (1998) The role of DNA mismatch repair in drug resistance. Clin Cancer Res 4: 1-6. (Pubitemid 28062870
-
(1998)
Clinical Cancer Research
, vol.4
, Issue.1
, pp. 1-6
-
-
Fink, D.1
Aebi, S.2
Howell, S.B.3
-
12
-
-
33644521213
-
Sprouty 2, an inhibitor of mitogenactivated protein kinase signaling, is down-regulated in hepatocellular carcinoma
-
Fong CW, Zhua MS, McKie AB, Ling SH, Mason V, Li R, Yusoff P, Lo TL, Leung HY, So SK, Guy GR (2006) Sprouty 2, an inhibitor of mitogenactivated protein kinase signaling, is down-regulated in hepatocellular carcinoma. Cancer Res 66: 2048-2058
-
(2006)
Cancer Res
, vol.66
, pp. 2048-2058
-
-
Fong, C.W.1
Zhua, M.S.2
McKie, A.B.3
Ling, S.H.4
Mason, V.5
Li, R.6
Yusoff, P.7
Lo, T.L.8
Leung, H.Y.9
So, S.K.10
Guy, G.R.11
-
13
-
-
84859771379
-
Molecular mechanisms of cisplatin resistance
-
Galluzzi L, Senovilla L, Vitale I, Michels J, Martins I, Kepp O, Castedo M, Kroemer G (2012) Molecular mechanisms of cisplatin resistance. Oncogene 31: 1869-1883
-
(2012)
Oncogene
, vol.31
, pp. 1869-1883
-
-
Galluzzi, L.1
Senovilla, L.2
Vitale, I.3
Michels, J.4
Martins, I.5
Kepp, O.6
Castedo, M.7
Kroemer, G.8
-
14
-
-
2442548880
-
The human frizzled 6 (hfz6) acts as a negative regulator of the canonical wnt-catenin signaling cascade
-
DOI 10.1074/jbc.M306421200
-
Golan T, Yaniv A, Bafico A, Liu G, Gazit A (2004) The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt . b-catenin signaling cascade. J Biol Chem 279: 14879-14888. (Pubitemid 38618878
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.15
, pp. 14879-14888
-
-
Golan, T.1
Yaniv, A.2
Bafico, A.3
Liu, G.4
Gazit, A.5
-
15
-
-
33645220428
-
Molecular profiling of platinum resistant ovarian cancer
-
Helleman J, Jansen MP, Span PN, van Staveren IL, Massuger LF, Meijer-van Gelder ME, Sweep FC, Ewing PC, van Der Burg ME, Stoter G, Nooter K, Berns EM (2006) Molecular profiling of platinum resistant ovarian cancer. Int J Cancer 118: 1963-1971
-
(2006)
Int J Cancer
, vol.118
, pp. 1963-1971
-
-
Helleman, J.1
Jansen, M.P.2
Span, P.N.3
Van Staveren, I.L.4
Massuger, L.F.5
Meijer-Van Gelder, M.E.6
Sweep, F.C.7
Ewing, P.C.8
Van Der Burg, M.E.9
Stoter, G.10
Nooter, K.11
Berns, E.M.12
-
16
-
-
77950188189
-
Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: The big picture
-
Helleman J, Smid M, Jansen MP, van Der Burg ME, Berns EM (2010) Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: The big picture. Gynecol Oncol 117: 170-176
-
(2010)
Gynecol Oncol
, vol.117
, pp. 170-176
-
-
Helleman, J.1
Smid, M.2
Jansen, M.P.3
Van Der Burg, M.E.4
Berns, E.M.5
-
17
-
-
61449172037
-
Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources
-
Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nat Protoc 4: 44-57
-
(2009)
Nat Protoc
, vol.4
, pp. 44-57
-
-
Huang, D.W.1
Sherman, B.T.2
Lempicki, R.A.3
-
18
-
-
0037125582
-
Paclitaxel plus carboplatin versus standard chemotherapy with either single-Agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: The ICON3 randomised trial
-
International Collaborative Ovarian Neoplasm Group
-
International Collaborative Ovarian Neoplasm Group (2002) Paclitaxel plus carboplatin versus standard chemotherapy with either single-Agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: The ICON3 randomised trial. Lancet 360: 505-515
-
(2002)
Lancet
, vol.360
, pp. 505-515
-
-
-
19
-
-
84858983547
-
KEGG for integration and interpretation of large-scale molecular datasets
-
Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M (2012) KEGG for integration and interpretation of large-scale molecular datasets. Nucleic Acids Res 40: D109-D114
-
(2012)
Nucleic Acids Res
, vol.40
-
-
Kanehisa, M.1
Goto, S.2
Sato, Y.3
Furumichi, M.4
Tanabe, M.5
-
20
-
-
79953192505
-
Integrated analysis of multiple microarray datasets identifies a reproducible survival predictor in ovarian cancer
-
Konstantinopoulos PA, Cannistra SA, Fountzilas H, Culhane A, Pillay K, Rueda B, Cramer D, Seiden M, Birrer M, Coukos G, Zhang L, Quackenbush J, Spentzos D (2011) Integrated analysis of multiple microarray datasets identifies a reproducible survival predictor in ovarian cancer. PLoS One 6: E18202
-
(2011)
PLoS One
, vol.6
-
-
Konstantinopoulos, P.A.1
Cannistra, S.A.2
Fountzilas, H.3
Culhane, A.4
Pillay, K.5
Rueda, B.6
Cramer, D.7
Seiden, M.8
Birrer, M.9
Coukos, G.10
Zhang, L.11
Quackenbush, J.12
Spentzos, D.13
-
21
-
-
0037085308
-
Liprin b1, a member of the family of LAR transmembrane tyrosine phosphatase-interacting proteins, is a new target for the metastasis-Associated protein S100A4 (Mts1
-
Kriajevska M, Fischer-LarsenM, Moertz E, Vorm O, Tulchinsky E, Grigorian M, Ambartsumian N, Lukanidin E (2002) Liprin b1, a member of the family of LAR transmembrane tyrosine phosphatase-interacting proteins, is a new target for the metastasis-Associated protein S100A4 (Mts1). J Biol Chem 277: 5229-5235
-
(2002)
J Biol Chem
, vol.277
, pp. 5229-5235
-
-
Kriajevska, M.1
Fischer-Larsen, M.2
Moertz, E.3
Vorm, O.4
Tulchinsky, E.5
Grigorian, M.6
Ambartsumian, N.7
Lukanidin, E.8
-
22
-
-
34247862218
-
Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells
-
DOI 10.1038/sj.onc.1210086, PII 1210086
-
Li J, Wood 3rd WH, Becker KG, Weeraratna AT, Morin PJ (2007) Gene expression response to cisplatin treatment in drug-sensitive and drugresistant ovarian cancer cells. Oncogene 26: 2860-2872. (Pubitemid 46701436
-
(2007)
Oncogene
, vol.26
, Issue.20
, pp. 2860-2872
-
-
Li, J.1
Wood III, W.H.2
Becker, K.G.3
Weeraratna, A.T.4
Morin, P.J.5
-
23
-
-
61349182713
-
Identification of a gene signature in cell cycle pathway for breast cancer prognosis using gene expression profiling data
-
Liu J, Campen A, Huang S, Peng SB, Ye X, Palakal M, Dunker AK, Xia Y, Li S (2008) Identification of a gene signature in cell cycle pathway for breast cancer prognosis using gene expression profiling data. BMC Med Genomics 1: 39
-
(2008)
BMC Med Genomics
, vol.1
, pp. 39
-
-
Liu, J.1
Campen, A.2
Huang, S.3
Peng, S.B.4
Ye, X.5
Palakal, M.6
Dunker, A.K.7
Xia, Y.8
Li, S.9
-
24
-
-
44249118962
-
ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis
-
Pabla N, Huang S, Mi QS, Daniel R, Dong Z (2008) ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis. J Biol Chem 283: 6572-6583
-
(2008)
J Biol Chem
, vol.283
, pp. 6572-6583
-
-
Pabla, N.1
Huang, S.2
Mi, Q.S.3
Daniel, R.4
Dong, Z.5
-
25
-
-
34249871106
-
The role of XAF1 in cancer
-
Plenchette S, Cheung HH, Fong WG, LaCasse EC, Korneluk RG (2007) The role of XAF1 in cancer. Curr Opin Investig Drugs 8: 469-476. (Pubitemid 46868069
-
(2007)
Current Opinion in Investigational Drugs
, vol.8
, Issue.6
, pp. 469-476
-
-
Plenchette, S.1
Cheung, H.H.2
Fong, W.G.3
Lacasse, E.C.4
Korneluk, R.G.5
-
26
-
-
42049107717
-
Down-regulation of mammalian sterile 20-like kinase 1 by heat shock protein 70 mediates cisplatin resistance in prostate cancer cells
-
DOI 10.1158/0008-5472.CAN-07-6248
-
Ren A, Yan G, You B, Sun J (2008) Down-regulation of mammalian sterile 20-like kinase 1 by heat shock protein 70 mediates cisplatin resistance in prostate cancer cells. Cancer Res 68: 2266-2274. (Pubitemid 351521800
-
(2008)
Cancer Research
, vol.68
, Issue.7
, pp. 2266-2274
-
-
Ren, A.1
Yan, G.2
You, B.3
Sun, J.4
-
27
-
-
76549107087
-
Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumours carrying a mutated RAS gene
-
Schaaf G, Hamdi M, Zwijnenburg D, Lakeman A, Geerts D, Versteeg R, Kool M (2010) Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumours carrying a mutated RAS gene. Cancer Res 70: 762-771
-
(2010)
Cancer Res
, vol.70
, pp. 762-771
-
-
Schaaf, G.1
Hamdi, M.2
Zwijnenburg, D.3
Lakeman, A.4
Geerts, D.5
Versteeg, R.6
Kool, M.7
-
28
-
-
0034887884
-
Cell cycle-mediated drug resistance: An emerging concept in cancer therapy
-
Shah MA, Schwartz GK (2001) Cell cycle-mediated drug resistance: An emerging concept in cancer therapy. Clin Cancer Res 7: 2168-2181. (Pubitemid 32751613
-
(2001)
Clinical Cancer Research
, vol.7
, Issue.8
, pp. 2168-2181
-
-
Shah, M.A.1
Schwartz, G.K.2
-
30
-
-
82655176997
-
Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin
-
Sherman-Baust CA, Becker KG, Wood Iii WH, Zhang Y, Morin PJ (2011) Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin. J Ovarian Res 4: 21
-
(2011)
J Ovarian Res
, vol.4
, pp. 21
-
-
Sherman-Baust, C.A.1
Becker, K.G.2
Wood III, W.H.3
Zhang, Y.4
Morin, P.J.5
-
31
-
-
78650647189
-
Spermassociated antigens as targets for cancer immunotherapy: Expression pattern and humoral immune response in cancer patients
-
Siliņa K, Zayakin P, Kalniņa Z, Ivanova L, Meistere I, Endzeliņš E, A-bols A, Stengre-vics A, Leja M, Ducena K, Kozirovskis V, Line-A (2011) Spermassociated antigens as targets for cancer immunotherapy: Expression pattern and humoral immune response in cancer patients. J Immunother 34: 28-44
-
(2011)
J Immunother
, vol.34
, pp. 28-44
-
-
Siliņa, K.1
Zayakin, P.2
Kalniņa, Z.3
Ivanova, L.4
Meistere, I.5
Endzeliņš, E.6
Abols, A.7
Stengrevics, A.8
Leja, M.9
Ducena, K.10
Kozirovskis, V.11
Line, A.12
-
32
-
-
84861457830
-
Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer
-
Sims AH, Zweemer AJM, Nagumo Y, Faratian D, Muir M, Dodd M, Um I, Kay C, Hasman M, Harrison DJ, Langdon SP (2012) Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer. Br J Cancer 106: 1779-1789
-
(2012)
Br J Cancer
, vol.106
, pp. 1779-1789
-
-
Sims, A.H.1
Zweemer, A.J.M.2
Nagumo, Y.3
Faratian, D.4
Muir, M.5
Dodd, M.6
Um, I.7
Kay, C.8
Hasman, M.9
Harrison, D.J.10
Langdon, S.P.11
-
33
-
-
33644872577
-
Limma: Linear models for microarray data
-
Gentleman RRW, Carey V, Dudoit S, Irizarry R, Huber Huber WRW (eds Springer: New York
-
Smyth GK (2005) Limma: Linear models for microarray data. In Bioinformatics and Computational Biology Solutions Using R and Bioconductor, Gentleman RRW, Carey V, Dudoit S, Irizarry R, Huber Huber WRW (eds) pp 397-420. Springer: New York
-
(2005)
Bioinformatics and Computational Biology Solutions Using R and Bioconductor
, pp. 397-420
-
-
Smyth, G.K.1
-
34
-
-
78149490372
-
Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-Treated patients with breast cancer
-
Taylor KJ, Sims AH, Liang L, Faratian D, Muir M, Walker G, Kuske B, Dixon JM, Cameron DA, Harrison DJ, Langdon SP (2010) Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-Treated patients with breast cancer. Breast Cancer Res S12: R39
-
(2010)
Breast Cancer Res
, Issue.S12
-
-
Taylor, K.J.1
Sims, A.H.2
Liang, L.3
Faratian, D.4
Muir, M.5
Walker, G.6
Kuske, B.7
Dixon, J.M.8
Cameron, D.A.9
Harrison, D.J.10
Langdon, S.P.11
-
35
-
-
52649085237
-
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
-
Australian Ovarian Cancer Study GroupGertig D DeFazio A Bowtell D.D.
-
Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, Johnson DS, Trivett MK, Etemadmoghadam D, Locandro B, Traficante N, Fereday S, Hung JA, Chiew YE, Haviv I. Australian Ovarian Cancer Study GroupGertig D, DeFazio A, Bowtell DD (2008) Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res 14: 5198-5208
-
(2008)
Clin Cancer Res
, vol.14
, pp. 5198-5208
-
-
Tothill, R.W.1
Tinker, A.V.2
George, J.3
Brown, R.4
Fox, S.B.5
Lade, S.6
Johnson, D.S.7
Trivett, M.K.8
Etemadmoghadam, D.9
Locandro, B.10
Traficante, N.11
Fereday, S.12
Hung, J.A.13
Chiew, Y.E.14
Haviv, I.15
-
36
-
-
79953300722
-
Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumour cell survival
-
Vanhecke E, Adriaenssens E, Verbeke S, Meignan S, Germain E, Berteaux N, Nurcombe V, Le Bourhis X, Hondermarck H (2011) Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumour cell survival. Clin Cancer Res 17: 1741-1752
-
(2011)
Clin Cancer Res
, vol.17
, pp. 1741-1752
-
-
Vanhecke, E.1
Adriaenssens, E.2
Verbeke, S.3
Meignan, S.4
Germain, E.5
Berteaux, N.6
Nurcombe, V.7
Le Bourhis, X.8
Hondermarck, H.9
-
37
-
-
80052025916
-
Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response
-
Wennemers M, Bussink J, Scheijen B, Nagtegaal ID, van Laarhoven HW, Raleigh JA, Varia MA, Heuvel JJ, Rouschop KM, Sweep FC, Span PN (2011) Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia response. Breast Cancer Res 13: R82
-
(2011)
Breast Cancer Res
, vol.13
-
-
Wennemers, M.1
Bussink, J.2
Scheijen, B.3
Nagtegaal, I.D.4
Van Laarhoven, H.W.5
Raleigh, J.A.6
Varia, M.A.7
Heuvel, J.J.8
Rouschop, K.M.9
Sweep, F.C.10
Span, P.N.11
-
38
-
-
70349307507
-
Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complexresistant ovarian cancer cells in vitro
-
Yanagie H, Hisa T, Ogata A, Miyazaki A, Nonaka Y, Nishihira T, Osada I, Sairennji T, Sugiyama H, Furuya Y, Kidani Y, Takamoto S, Takahashi H, Eriguchi M (2009) Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complexresistant ovarian cancer cells in vitro. Biomed Pharmacother 63: 553-560
-
(2009)
Biomed Pharmacother
, vol.63
, pp. 553-560
-
-
Yanagie, H.1
Hisa, T.2
Ogata, A.3
Miyazaki, A.4
Nonaka, Y.5
Nishihira, T.6
Osada, I.7
Sairennji, T.8
Sugiyama, H.9
Furuya, Y.10
Kidani, Y.11
Takamoto, S.12
Takahashi, H.13
Eriguchi, M.14
-
39
-
-
80053371042
-
CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1a
-
Yoon H, Lim JH, Cho CH, Huang LE, Park JW (2011) CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1a. Biochim Biophys Acta 1813: 2008-2016.
-
(2011)
Biochim Biophys Acta
, vol.1813
, pp. 2008-2016
-
-
Yoon, H.1
Lim, J.H.2
Cho, C.H.3
Huang, L.E.4
Park, J.W.5
|